James A. Kelley
Impact in
- Virology top 2%
- HIV Research and Treatment
- Physiology top 1%
- Adenosine and Purinergic Signaling
Papers in
- Virology 15
- HIV Research and Treatment 15
-
- HIV/AIDS drug development and treatment 36
- Co-authors
- Víctor E. MárquezJohn S. DriscollJ. A. BertrandDavid G. JohnsDavid A. CooneyHarry FordJeri S. RothHiroaki Mitsuya
- Journals
- Journal of Medicinal Chemistry (18 papers)The Journal of Organic Chemistry (11 papers)Bioorganic & Medicinal Chemistry (6 papers)Biochemical Pharmacology (5 papers)Journal of Pharmaceutical Sciences (4 papers)
- Partner nations
- United StatesIsraelArgentina
In The Last Decade
James A. Kelley
136 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 135
- Virology 358
- Physiology 223
- Infectious Diseases 763
- Organic Chemistry 863
- Molecular Biology 2.0k
Countries citing papers authored by James A. Kelley
This map shows the geographic impact of James A. Kelley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Kelley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Kelley more than expected).
Fields of papers citing papers by James A. Kelley
This network shows the impact of papers produced by James A. Kelley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Kelley. The network helps show where James A. Kelley may publish in the future.
Co-authors
The 25 scholars most cited alongside James A. Kelley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 35 | |
| 2 | 2017 | 56 | |
| 3 | 2017 | 8 | |
| 4 | 2015 | 12 | |
| 5 | 2014 | 22 | |
| 6 | 2010 | 3 | |
| 7 | 2009 | 4 | |
| 8 | 2008 | 28 | |
| 9 | 2005 | 73 | |
| 10 | 2005 | 11 | |
| 11 | 2003 | 19 | |
| 12 | 2003 | 5 | |
| 13 | 2001 | 8 | |
| 14 | Information Operations for the Ground Commander | 1997 | 1 |
| 15 | 1997 | 1 | |
| 16 | 1991 | 9 | |
| 17 | Phase I and pharmacokinetic study of arabinofuranosyl-5-azacytosine (fazarabine, NSC 281272). | 1990 | 15 |
| 18 | 1988 | 29 | |
| 19 | 1987 | 71 | |
| 20 | EVALUATION OF PHOSPHORIC ACID FOR STABILIZATION OF FINE- GRAINED PLASTIC SOILS | 1962 | 1 |
About James A. Kelley
James A. Kelley is a scholar working on Virology, Infectious Diseases, Organic Chemistry, Pharmaceutical Science and Physiology, having authored 139 papers that have together received 3.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (36 papers), Biochemical and Molecular Research (26 papers), Cytomegalovirus and herpesvirus research (16 papers), Chemical Synthesis and Analysis (15 papers), HIV Research and Treatment (15 papers), DNA and Nucleic Acid Chemistry (9 papers), Click Chemistry and Applications (8 papers) and Cancer therapeutics and mechanisms (8 papers). The work is most often cited by research in Virology (358 citations), Physiology (223 citations), Infectious Diseases (763 citations), Organic Chemistry (863 citations) and Molecular Biology (2.0k citations). James A. Kelley has collaborated with scholars based in United States, Israel and Argentina. Frequent co-authors include Víctor E. Márquez, John S. Driscoll, J. A. Bertrand, David G. Johns, David A. Cooney, Harry Ford, Jeri S. Roth, Hiroaki Mitsuya, James A. Cella and Hiremagalur N. Jayaram. Their work appears in journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry, Bioorganic & Medicinal Chemistry, Biochemical Pharmacology and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.